Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 919407a63bab6426-LAX IP: 101.37.83.79 UTC time: 2025-02-28T23:00:17+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Like

Share Bookmark

0 0 0 0 0 0 0

More from this channel

Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study

Comments (0)